NON-SMALL CELL LUNG CANCER METASTATIC
Clinical trials for NON-SMALL CELL LUNG CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER METASTATIC trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat lung cancer: targeted drug shows promise in late-stage trial
Disease control OngoingThis study tests an experimental drug called patritumab deruxtecan in people with advanced non-small cell lung cancer that has a specific EGFR mutation and has stopped responding to standard treatments. The main goal is to see if the drug can shrink tumors. About 277 participants…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New hope for rare lung cancer mutations: targeted pill shows promise
Disease control OngoingThis study tests a daily pill called dacomitinib in 30 people with advanced lung cancer that has uncommon EGFR gene changes. The goal is to see if the drug can shrink tumors or stop them from growing. Participants take the drug until their cancer progresses or they no longer bene…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Hope for seniors: immunotherapy combo tested in advanced lung cancer
Disease control OngoingThis study looks at whether adding the immunotherapy drug atezolizumab to standard chemotherapy helps elderly patients (70+) with advanced non-small-cell lung cancer live longer. About 510 participants will receive either chemo alone or chemo plus atezolizumab. The goal is to see…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE3 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC
-
New combo offers hope for lung cancer patients after immunotherapy fails
Disease control OngoingThis study looks at a combination of three drugs (bevacizumab, nab-paclitaxel, and platinum) as a second treatment for people with a certain type of advanced lung cancer that got worse after initial immunotherapy. The goal is to see if this combo can shrink tumors and help patien…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC